Development and Application of Chymase Inhibitors: Therapeutic Potential of a Specific Chymase Inhibitor in Atopic Dermatitis
Authors:
Open Access
- 1 January 2002
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 90 (3) , 214-217
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 14 references indexed in Scilit:
- Rat mast cell protease‐I enhances immunoglobulin E production by mouse B cells stimulated with interleukin‐4Immunology, 2001
- Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory diseaseClinical & Experimental Allergy, 1999
- Effect of FK 506 in the Treatment of Autoimmune Glomerulonephritis in Brown Norway RatsNephron, 1999
- No Evidence for an Association between a Variant of the Mast Cell Chymase Gene and Atopic Dermatitis Based on Case-Control and Haplotype-Relative-Risk AnalysesHuman Heredity, 1998
- Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga miceInternational Immunology, 1997
- Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterizationAllergology International, 1997
- Association between genetic variants of mast-cell chymase and eczemaThe Lancet, 1996
- Scratching behavior induced by pruritogenic but not algesiogenic agents in miceEuropean Journal of Pharmacology, 1995
- The Effect of Mast Cell Chymase on Extracellular Matrix: Studies in Autoimmune Thyroiditis and in Cultured Thyroid CellsInternational Archives of Allergy and Immunology, 1992
- Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes.Journal of Experimental Medicine, 1984